| TITLE |
DATE |
PRICE |
| Beijing Minhai Biotechnology Co., Ltd.-Company Report |
1/7/10 |
$750.00 |
|
|
| Bavarian Nordic A/S-Company Report |
1/7/10 |
$750.00 |
|
|
| Avir Green Hills Biotechnology AG-Company Report |
1/7/10 |
$750.00 |
|
|
| Ark Therapeutics Group plc-Company Report |
1/7/10 |
$750.00 |
|
|
| AntiCancer, Inc-Company Report |
1/7/10 |
$750.00 |
|
|
| AMT (Amsterdam Molecular Therapeutics)-Company Report |
1/7/10 |
$750.00 |
|
|
| American Biologics-Company Report |
1/7/10 |
$750.00 |
|
|
| Ambryx Biotechnology Inc.-Company Report |
1/7/10 |
$750.00 |
|
|
| Altor BioScience Corporation-Company Report |
1/7/10 |
$750.00 |
|
|
| Active Biotech AB-Company Report |
1/7/10 |
$750.00 |
|
|
| Actis Biologics, Inc.-Company Report |
1/7/10 |
$750.00 |
|
|
| Actar AB-Company Report |
1/7/10 |
$750.00 |
|
|
| Acambis-Company Report |
1/7/10 |
$750.00 |
|
|
| Ablynx nv-Company Report |
1/7/10 |
$750.00 |
|
|
| AbGenomics International Inc.-Company Report |
1/7/10 |
$750.00 |
|
|
| 4SC AG-Company Report |
1/7/10 |
$750.00 |
|
|
| XOMA Ltd.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| ViroPharma Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Vical Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Theragenics Corp.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Targeted Genetics Corp.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Techne Corp.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Transgenomic Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| StemCells Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Sequenom Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Sangamo Biosciences Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Seattle Genetics Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Stem Cell Innovations, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Rosetta Genomics, Ltd.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| PDL BioPharma, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Pacific Biometrics Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Novavax, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Neurocrine Biosciences Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Myriad Genetics Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Micromet, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Millipore Corp.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Medarex, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Maxygen, Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Martek Biosciences Corp.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| InterMune Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Inhibitex Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| Immunomedics Inc.-Deals & Alliances Report |
1/7/10 |
$600.00 |
|
|
| PDL BioPharma Inc-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Pharmacyclics Inc-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Opko Health, Inc.-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Oncothyreon, Inc.-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Novavax Inc-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Nektar Therapeutics-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Neurocrine Biosciences Inc-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| Micromet Inc-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
| MicroIslet, Inc.-Therapeutic Competitors |
1/7/10 |
$350.00 |
|
|
